Clinical Trial Update: Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

View source ↗

Summary

This clinical trial update notes the completion of a study characterizing apolipoprotein A-I pathways in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED